GIGA SOLAR MATERIALS CORP.Download PDFPatent Trials and Appeals BoardDec 22, 20202020000310 (P.T.A.B. Dec. 22, 2020) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 14/920,140 10/22/2015 CHIH-HSIEN YEH TSA1-PAU09US 5184 97066 7590 12/22/2020 Innovation Capital Law Group, LLP 19800 MacArthur Blvd. Suite 280 Irvine, CA 92612 EXAMINER TRAN, UYEN M ART UNIT PAPER NUMBER 1726 NOTIFICATION DATE DELIVERY MODE 12/22/2020 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): eofficeaction@appcoll.com processing@icaplaw.com vlin@icaplaw.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE ____________ BEFORE THE PATENT TRIAL AND APPEAL BOARD ____________ Ex parte CHIH-HSIEN YEH, PO-YANG SHIH, and PI-YU HSIN Appeal 2020-000310 Application 14/920,140 Technology Center 1700 ____________ Before ROMULO H. DELMENDO, JEFFREY T. SMITH, and BEVERLY A. FRANKLIN, Administrative Patent Judges. DELMENDO, Administrative Patent Judge. DECISION ON APPEAL The Appellant1 appeals under 35 U.S.C. § 134(a) from the Primary Examiner’s final decision to reject claims 1, 2, and 4–9.2 We have jurisdiction under 35 U.S.C. § 6(b). We affirm. 1 We use the word “Appellant” to refer to “applicant” as defined in 37 C.F.R. § 1.42—i.e., Giga Solar Materials Corp. (Application Data Sheet filed October 22, 2015 at 5), which is also identified as the real party in interest (Appeal Brief filed June 13, 2019 (“Appeal Br.”), as revised February 3, 2020, at 4). 2 See Appeal Br. 10–13; Reply Brief filed October 2, 2019 (“Reply Br.”) at 4–6; Final Office Action entered February 28, 2019 (“Final Act.”) at 3–6; Examiner’s Answer entered August 28, 2019 (“Ans.”) at 4–7. Appeal 2020-000310 Application 14/920,140 2 I. BACKGROUND The subject matter on appeal relates to a conductive paste and articles having such a paste applied thereon (Specification filed October 22, 2015 (“Spec.”) at 1, ll. 5–7). Representative claim 1 is reproduced from the Claims Appendix to the Appeal Brief, as follows: 1. A conductive paste for forming a front electrode in a solar cell, the conductive paste comprising: (a) about 85% to about 99.5% by weight of a conductive metal based on a weight of solids; (b) about 0.5% to about 15% by weight of a lead-free glass frit containing tellurium-bismuth-lithium-oxide, based on the weight of solids, wherein the tellurium oxide is present in an amount of about 60 wt.% to about 90 wt.%, the bismuth oxide is present in an amount of about 0.1 wt.% to about 20 wt.%, the lithium oxide is present in an amount of about 0.1 wt.% to about 20 wt.% and aluminum oxide is present in an amount of about 0.5 wt.% to about 3 wt.%; and (c) an organic vehicle; wherein the weight of solids is the total weight of the conductive metal (a) and the lead-free glass frit (b), and wherein the conductive paste is free from silica. (Appeal Br. 15). II. REJECTION ON APPEAL Claims 1, 2, and 4–9 stand rejected under 35 U.S.C. § 103 as unpatentable over Park et al.3 (“Park”) (Ans. 4–7; Final Act. 3–6). 3 WO 2014/126293 A1, published March 20, 2013. The Examiner relies on the corresponding published United States Application US 2016/0013331 A1, published January 14, 2016, as an English language translation (Ans. 4). Therefore, our citations are to the published United States application. Appeal 2020-000310 Application 14/920,140 3 III. DISCUSSION 1. Grouping of Claims The Appellant relies on the same arguments for all claims on appeal, focusing only on independent claim 1 (Appeal Br. 10–13). Therefore, claims 2 and 4–9 stand or fall with claim 1, which we select as representative. 37 C.F.R. § 41.37(c)(1)(iv). 2. The Examiner’s Position The Examiner’s findings and reasoning in support of the rejection are found in the Answer at pages 4–7 and the Final Action at 3–4. We adopt them as our own, except as discussed below. In re Cree, Inc., 818 F.3d 694, 698 n.2 (Fed. Cir. 2016); In re Brana, 51 F.3d 1560, 1564 n.13 (Fed. Cir. 1995). 3. The Appellant’s Contentions The Appellant contends that no reasonable expectation of success in using aluminum oxide, as specified in claim 1, exists because Park teaches aluminum oxide as one oxide among a large number of oxides that includes 31 other oxides (Appeal Br. 10). According to the Appellant, the glass frit composition art is not predictable, as evidenced by the results reported in the current Specification and Park (Table 1) (Appeal Br. 10). Furthermore, the Appellant argues that no motivation to select aluminum oxide exists (id. at 11 (citing, e.g., In re Baird, 16 F.3d 380, 382 (Fed. Cir. 1994)). Additionally, the Appellant argues that no motivation to use aluminum oxide in the more narrow range recited in claim 1 exists (Appeal Br. 12–13). As for secondary considerations, the Appellant argues that Examples G2, G4, G8, G10, and G13 discussed in the Specification (Tables 1 and 3) constitute Appeal 2020-000310 Application 14/920,140 4 evidence of unexpected results in terms of efficiency and resistance over the examples disclosed in Park’s Table 1 (Appeal Br. 12). 4. Opinion We have fully considered the Appellant’s arguments and proffered evidence but find them insufficient to identify reversible error in the Examiner’s rejection. In re Jung, 637 F.3d 1356, 1365 (Fed. Cir. 2011). Contrary to the Appellant’s belief, Baird is not controlling because: Park discloses the incorporation of aluminum oxide as one of only a limited number (32) of possible additional metal oxide choices; and Park does not teach away from using aluminum oxide but, rather, names it as a suitable choice (Park ¶ 36). Cf. Baird, 16 F.3d at 383 (a prior art “disclosure of millions of compounds does not render obvious a claim to three compounds, particularly when that disclosure indicates a preference leading away from the claimed compounds” (emphases added)). Instead, other precedents are more on point. KSR Int’l Co. v. Teleflex Inc., 550 U.S. 398, 416 (2007) (“[W]hen a patent claims a structure already known in the prior art that is altered by the mere substitution of one element for another known in the field, the combination must do more than yield a predictable result.”); Id. at 421 (“When there is a design need or market pressure to solve a problem and there are a finite number of identified, predictable solutions, a person of ordinary skill has good reason to pursue the known options within his or her technical grasp.”); Wm. Wrigley Jr. Co. v. Cadbury Adams USA LLC, 683 F.3d 1356, 1364–65 (Fed. Cir. 2012) (explaining that a “strong case of obviousness” exists where the combination of ingredients recited in the claims were based on selections from a finite number of identified, predictable solutions); Merck & Co., Inc. v. Biocraft Appeal 2020-000310 Application 14/920,140 5 Labs., Inc., 874 F.2d 804, 807 (Fed. Cir. 1989) (“That the [reference] discloses a multitude of effective combinations does not render any particular formulation less obvious.”). The Appellant’s attack on Park regarding the amount of aluminum oxide that may be added is also without merit. Park teaches an aluminum oxide amount of 0.1–5 wt.% relative to the total weight of the glass frit (Park ¶ 36), which does not substantially deviate from that recited in claim 1 (“an amount of about 0.5 wt.% to about 3 wt.%”) (Appeal Br. 15). Cf. Perricone v. Medicis Pharm. Corp., 432 F.3d 1368, 1377 (Fed. Cir. 2005) (“[The prior art]’s disclosed range of concentration also does not exactly correspond to [the Patentee]’s claimed range. [The prior art]’s disclosure nonetheless discloses and anticipates [the Patentee]’s particular claimed ‘effective amount’ ranges.”). As for unexpected results, we agree with the Examiner (Ans. 6) that the proffered showing is insufficient because Park’s examples (Park ¶¶ 51– 55) and Examples G2, G4, G8, G10, and G13 in the current Specification (Spec. Tables 1–3) are not fairly comparative—i.e., back-to-back runs. In re Dunn, 349 F.2d 433, 439 (CCPA 1965) (“While we do not intend to slight the alleged improvements, we do not feel it an unreasonable burden on appellants to require comparative examples relied on for non-obviousness to be truly comparative. The cause and effect sought to be proven is lost here in the welter of unfixed variables.”). In addition, consistent with the Examiner’s position, the Inventors’ Examples G2, G8, and G13 are outside the scope of claim 1 because the compositions disclosed in these examples include silica, which is explicitly excluded by the limitation “wherein the conductive paste is free from silica” Appeal 2020-000310 Application 14/920,140 6 (Appeal Br. 15).4 In this regard, the Appellant’s argument in the Reply Brief (Reply Br. 4) that “[t]he language of claim 1 does not exclude the inclusion of silica as one of the components of the lead-free glass frit (b)” is based on an erroneous understanding of the claim as a whole because the glass frit (b) component is part of the claimed conductive paste. Hence, Examples G4 and G10 are the only examples with compositions that fall within the scope of claim 1, but they are not sufficiently comprehensive as to constitute a showing that is commensurate in scope with claim 1. See, e.g., In re Harris, 409 F.3d 1339, 1344 (Fed. Cir. 2005) (“Harris needed to show results covering the scope of the claimed range. Alternatively Harris needed to narrow the claims.”). Lastly, the alleged improvement in terms of efficiency (17.76% and 17.75% for Examples G4 and G8, respectively) over Park’s average of 16.67% (Appeal Br. 12) can hardly be said to be significant, let alone unexpected. Harris, 409 F.3d at 1344 (“The 32–43% increase in stress- rupture life . . . does not represent a ‘difference in kind’ that is required to show unexpected results.”). Therefore, we sustain the Examiner’s rejection as maintained against claim 1. IV. CONCLUSION For these reasons, we uphold the Examiner’s rejection. 4 As the Appellant points out (Reply Br. 4), the Examiner errs (Ans. 6) in finding that Examples G4 and G8 have LiO2 amounts (13.5 wt.% and 16.5 wt.%, respectively) outside the range recited in claim 1 (“about 0.1 wt.% to about 20 wt.%”). The Examiner’s error, however, is harmless as it does not affect the overall insufficiency of the proffered showing. Appeal 2020-000310 Application 14/920,140 7 V. DECISION SUMMARY In summary: Claims Rejected 35 U.S.C. § Reference(s)/Basis Affirmed Reversed 1, 2, 4–9 103 Park 1, 2, 4–9 No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED Copy with citationCopy as parenthetical citation